These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2339463)

  • 1. Cerebral sinus thrombosis as a potential hazard of antifibrinolytic treatment in menorrhagia.
    Achiron A; Gornish M; Melamed E
    Stroke; 1990 May; 21(5):817-9. PubMed ID: 2339463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral thrombosis associated with Amicar therapy.
    Hoffman EP; Koo AH
    Radiology; 1979 Jun; 131(3):687-9. PubMed ID: 441374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epsilon-aminocaproic acid (EACA).
    Griffin JD; Ellman L
    Semin Thromb Hemost; 1978; 5(1):27-40. PubMed ID: 568312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of deep vein thrombosis in prostatectomised patients following the administration of the fibrinolytic inhibitor, aminocaproic acid (EACA).
    Sinclair J; Forbes CD; Prentice CR; Scott R
    Urol Res; 1976 Nov; 4(3):129-31. PubMed ID: 797086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive thrombosis following central venous catheterization--a relationship to antifibrinolytic therapy?
    Hayhurst MD
    S Afr Med J; 1983 May; 63(21):797. PubMed ID: 6845102
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report.
    Tubbs RR; Benjamin SP; Dohn DE
    J Neurosurg; 1979 Jul; 51(1):94-7. PubMed ID: 448423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.
    Burchiel KJ; Hoffman JM; Bakay RA
    Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute renal failure due to high-grade obstruction following therapy with epsilon-aminocaproic acid.
    Pitts TO; Spero JA; Bontempo FA; Greenberg A
    Am J Kidney Dis; 1986 Dec; 8(6):441-4. PubMed ID: 3812474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of menorrhagia with epsilon aminocaproic acid. A double blind investigation.
    Nilsson L; Rybo G
    Acta Obstet Gynecol Scand; 1965; 44(3):467-73. PubMed ID: 5324474
    [No Abstract]   [Full Text] [Related]  

  • 10. Obstruction of solitary kidney due to epsilon-aminocaproic-acid-induced fibrin clot formation.
    Geltzeiler J; Schwartz D
    Urology; 1984 Jul; 24(1):64-6. PubMed ID: 6740850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fatal massive intravascular coagulation during phlebography. Responsibility of epsilon-aminocaproic acid?].
    Coste F; Tremolières F; Bousquet M; Martin E; Dreyfuss D; Levesque M; Barge J
    Presse Med; 1985 Apr; 14(15):832-4. PubMed ID: 3158905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdomyolysis during treatment with epsilon-aminocaproic acid.
    Britt CW; Light RR; Peters BH; Schochet SS
    Arch Neurol; 1980 Mar; 37(3):187-8. PubMed ID: 7356431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why may epsilon-aminocaproic acid (EACA) induce myopathy in man? Report of a case and literature review.
    Galassi G; Gibertoni M; Corradini L; Colombo A
    Ital J Neurol Sci; 1983 Dec; 4(4):489-92. PubMed ID: 6674249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myopathy induced by epsilon-aminocaproic acid. Case report.
    Brown JA; Wollmann RL; Mullan S
    J Neurosurg; 1982 Jul; 57(1):130-4. PubMed ID: 7086489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ejaculation due to epsilon aminocaproic acid.
    Evans BE; Aledort LM
    N Engl J Med; 1978 Jan; 298(3):166-7. PubMed ID: 619254
    [No Abstract]   [Full Text] [Related]  

  • 16. Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases.
    MacKay AR; Sang U H; Weinstein PR
    J Neurosurg; 1978 Oct; 49(4):597-601. PubMed ID: 690689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epsilon-aminocaproic acid myopathy. Report of a case and literature review.
    Vanneste JA; van Wijngaarden GK
    Eur Neurol; 1982; 21(4):242-8. PubMed ID: 7117311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purpuric rash due to epsilon-aminocaproic acid.
    Chakrabarti A; Collett KA
    Br Med J; 1980 Jul; 281(6234):197-8. PubMed ID: 6447530
    [No Abstract]   [Full Text] [Related]  

  • 19. Venous thrombosis.
    Tahmouresie A
    J Neurosurg; 1979 Aug; 51(2):266. PubMed ID: 448439
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute delirious state after epsilon-aminocaproic acid.
    Wysenbeek AJ; Sella A; Vardi M; Yeshurun D
    Lancet; 1978 Jan; 1(8057):221. PubMed ID: 74653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.